Table 2.
Specificity of Alloantibodies Among Alloimmunized Patients, Compared to the Cooperative Study of SCD (CSSCD)9
Specificity | % of 338 alloimm CSSCD Pts |
% of 87 alloimm Duke- UNC Pts |
P value | Specificity | % of 338 alloimm CSSCD Pts |
% of 87 alloimm Duke- UNC Pts |
P value |
---|---|---|---|---|---|---|---|
D | 13.0 | 11.49 | 0.704 | M | 7.7 | 17.24 | 0.013* |
C | 30.2 | 35.63 | 0.364 | N | 1.5 | 1.15 | 1.000 |
c | 3.0 | 2.30 | 1.000 | S | 9.2 | 29.89 | <0.0001* |
E | 42.3 | 45.98 | 0.538 | s | 1.5 | 2.30 | 0.636 |
e | 4.4 | 2.30 | 0.543 | Jka | 1.8 | 3.45 | 0.398 |
V | 2.4 | 6.90 | 0.046* | Jkb | 10.7 | 19.54 | 0.025* |
K | 28.1 | 19.54 | 0.106 | Fya or Fy3 | 18.6 | 24.14 | 0.251 |
Statistically significant difference between the two studies